381
Participants
Start Date
June 29, 2022
Primary Completion Date
March 24, 2025
Study Completion Date
March 31, 2026
Nab-paclitaxel 80 mg/m^2
Nab-paclitaxel is administered as intravenous (IV) infusion over 30-40 minutes on Days 1, 8, and 15 of each 28-day cycle.
Relacorilant 150 mg once daily (QD)
Relacorilant is administered as capsules for oral dosing.
Nab-paclitaxel 100 mg/m^2
Nab-paclitaxel is administered as IV infusion on Day 1, 8, and 15 of each 28-day cycle.
Site 161, Roma
Site 322, Budapest
Site 391, Rosario
Site 426, St Leonards
Site 414, Melbourne
Site 108, Leuven
Site 419, Melbourne
Site 325, Hasselt
Site 290, Debrecen
Site 417, Benowa
Site 326, Charleroi
Site 348, Győr
Site 328, Aalst
Site 293, Torino
Site 397, Gyeonggi-do
Site 275, Flushing
Site 127, Pittsburgh
Site 337, Bethlehem
Site 311, San Sebastián
Site 122, Milan
Site 323, Plérin
Site 365, Richmond
Site 300, Norfolk
Site 295, Pavia
Site 009, Atlanta
Site 272, Atlanta
Site 372, Gainesville
Site 319, Treviso
Site 291, Savannah
Site 335, Miami Beach
Site 042, Weston
Site 347, Montpellier
Site 320, Legnago
Site 281, Nashville
Site 368, Germantown
Site 279, Louisville
Site 409, Seoul
Site 298, Cincinnati
Site 304, Cincinnati
Site 330, Valencia
Site 339, Indianapolis
Site 121, Milwaukee
Site 307, Nancy
Site 276, Rapid City
Site 306, Lille
Site 315, Evanston
Site 314, Hinsdale
Site 346, Urbana
Site 200, Overland Park
Site 334, Overland Park
Site 289, Paris
Site 312, Bedford
Site 297, Fort Worth
Site 301, The Woodlands
Site 392, San Antonio
Site 229, Austin
Site 032, Aurora
Site 318, Phoenix
Site 277, Tucson
Site 292, Albuquerque
Site 364, La Jolla
Site 350, Irvine
Site 316, Solvang
Site 278, San Francisco
Site 014, San Francisco
Site 150, Palo Alto
Site 321, Catania
Site 280, Portland
Site 317, Portland
Site 049, Portland
Site 080, Jerusalem
Site 309, Haifa
Site 203, Tel Aviv
Site 128, Boston
Site 288, New Brunswick
Site 393, CABA
Site 381, Ciudad Autonoma de Buenos Aire
Site 415, Córdoba
Site 401, Córdoba
Site 395, Córdoba
Site 404, Mendoza
Site 412, Rosario
Site 109, Brussels
Site 327, Liège
Site 424, Brasília
Site 382, Fortaleza
Site 384, Salvador
Site 383, Belo Horizonte
Site 390, Natal
Site 413, São Paulo
Site 413, São Paulo
Site 421, Porto Alegre
Site 380, Rio de Janeiro
Site 376, São Paulo
Site 389, São Paulo
Site 374, São Paulo
Site 001, São Paulo
Site 117, Toronto
Site 273, Montreal
Site 310, Nice
Site 124, Rome
Site 341, Gdynia
Site 331, Poznan
Site 329, Siedlce
Site 399, Seoul
Site 398, Seoul
Site 403, Seoul
Site 400, Seoul
Site 396, Seoul
Site 402, Seoul
Site 349, Badalona
Site 367, Brighton
Site 351, Taunton
Site 366, Cheltenham
Site 055, London
Site 344, Manchester
Site 345, Northwood
Lead Sponsor
Gynecologic Oncology Group
NETWORK
Corcept Therapeutics
INDUSTRY